Malignant Pleural Effusions Clinical Trial
The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05543330 -
A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
|
Phase 1/Phase 2 | |
Completed |
NCT00758316 -
A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions
|
Phase 3 | |
Completed |
NCT03869697 -
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
|
Phase 1 | |
Enrolling by invitation |
NCT02092155 -
Biomarker Levels During Indwelling Pleural cAtheter Sample Testing
|
||
Recruiting |
NCT00430664 -
A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis
|
N/A | |
Completed |
NCT00188474 -
A Quality of Life Study re Management of Malignant Pleural Effusions
|
N/A | |
Terminated |
NCT02623959 -
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
|
Phase 4 |